The Role of Sphingolipids in the Pathogenesis of Psoriasis
- PMID: 36557209
- PMCID: PMC9785224
- DOI: 10.3390/metabo12121171
The Role of Sphingolipids in the Pathogenesis of Psoriasis
Abstract
Psoriasis is a complex, chronic, immunologically mediated disease which involves skin and joints. Psoriasis is commonly connected with numerous other diseases such as liver diseases, metabolic syndrome, impaired glucose tolerance, diabetes mellitus, atherosclerosis, hypertension, and ischemic heart disease. Interestingly, comorbidities of psoriasis are an attention-grabbing issue. Additionally, it can cause impairment of quality of life and may be associated with depressive disorders. Altered levels of ceramides in psoriatic skin may lead to anti-apoptotic and pro-proliferative states, consequently leading to an over-proliferation of keratinocytes and the development of skin lesions. The pathophysiology of psoriasis and its comorbidities is not fully understood yet. Sphingolipids (including ceramides) and their disturbed metabolism may be the link between psoriasis and its comorbidities. Overall, the goal of this review was to discuss the role of sphingolipid disturbances in psoriasis and its comorbidities. We searched the PubMed database for relevant articles published before the beginning of May 2022. The systematic review included 65 eligible original articles.
Keywords: ceramide; ceramide S1P receptor; psoriasis; sphingolipid; sphingomyelin; sphingosine 1-phosphate; sphingosine kinase; sphingosine lipid signaling.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease.Int J Mol Sci. 2023 Jul 12;24(14):11336. doi: 10.3390/ijms241411336. Int J Mol Sci. 2023. PMID: 37511095 Free PMC article.
-
Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.Arch Dermatol Res. 2017 Mar;309(2):79-86. doi: 10.1007/s00403-016-1709-9. Epub 2016 Dec 17. Arch Dermatol Res. 2017. PMID: 27988894 Free PMC article.
-
Crosstalk between Serum and Skin Sphingolipids in Psoriasis.Int J Mol Sci. 2023 Oct 3;24(19):14872. doi: 10.3390/ijms241914872. Int J Mol Sci. 2023. PMID: 37834321 Free PMC article.
-
The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis.Cells. 2023 Sep 26;12(19):2352. doi: 10.3390/cells12192352. Cells. 2023. PMID: 37830566 Free PMC article. Review.
-
The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.Mol Neurobiol. 2019 Aug;56(8):5436-5455. doi: 10.1007/s12035-018-1448-3. Epub 2019 Jan 5. Mol Neurobiol. 2019. PMID: 30612333 Free PMC article. Review.
Cited by
-
Ceramides during Pregnancy and Obstetrical Adverse Outcomes.Metabolites. 2023 Nov 8;13(11):1136. doi: 10.3390/metabo13111136. Metabolites. 2023. PMID: 37999232 Free PMC article. Review.
-
Revealing the roles of glycosphingolipid metabolism pathway in the development of keloid: a conjoint analysis of single-cell and machine learning.Front Immunol. 2023 Apr 24;14:1139775. doi: 10.3389/fimmu.2023.1139775. eCollection 2023. Front Immunol. 2023. PMID: 37168863 Free PMC article.
-
Perturbations of Glutathione and Sphingosine Metabolites in Port Wine Birthmark Patient-Derived Induced Pluripotent Stem Cells.Metabolites. 2023 Aug 31;13(9):983. doi: 10.3390/metabo13090983. Metabolites. 2023. PMID: 37755263 Free PMC article.
-
Psoriasis, stem cells, and obesity: metabolic exploration for therapeutics.J Med Life. 2025 Jul;18(7):608-620. doi: 10.25122/jml-2025-0033. J Med Life. 2025. PMID: 40893809 Free PMC article. Review.
-
Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis.Metabolites. 2023 Feb 16;13(2):291. doi: 10.3390/metabo13020291. Metabolites. 2023. PMID: 36837912 Free PMC article. Review.
References
-
- Łuczaj W., Wroński A., Domingues P., Rosário Domingues M., Skrzydlewska E. Lipidomic Analysis Reveals Specific Differences between Fibroblast and Keratinocyte Ceramide Profile of Patients with Psoriasis Vulgaris Molecules. Clin. Immunol. 2020;214:108397. doi: 10.1016/j.clim.2020.108397. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources